Skip to content

Comparative Performance of Healthcare Systems Across Models and Countries

Executive summary

No major healthcare financing model wins on every dimension. The best composite performers in this synthesis are systems that combine universal or near-universal coverage, low direct charges at the point of care, regulated prices, and relatively strong primary care or coordinated delivery. On that basis, Japan, France, Sweden, the Netherlands, and Taiwan stand out as the strongest combinations of outcomes, equity, and cost control, while Germany performs very well on access and financial protection but at a higher cost and with less impressive population outcomes than its spending would predict. The United Kingdom still offers comparatively good population outcomes for the money, but current access strain materially weakens the patient experience. Canada remains equitable on core coverage and overall outcomes, yet timeliness is its major weakness. The United States is the clearest low-value outlier: it spends far more than every peer system while producing worse population health and much weaker equity. citeturn16view3turn16view5turn11view1turn11view4turn16view6turn16view8turn16view0turn16view2turn35search3turn35search4turn36view0turn11view3turn13view1turn13view2turn12view2turn11view5turn13view3turn13view5turn43view0turn44search2turn44search6

For patients, the strongest systems are not necessarily the cheapest, but they tend to share the same design features: automatic enrollment or legal universality, mandatory prepayment, tighter price regulation, lower administrative friction, and better protection against direct out-of-pocket exposure. OECD country notes show Germany, France, the Netherlands, Sweden, Japan, the United Kingdom, and Canada all cover the full population for a core set of services, while recent Taiwan Ministry of Health and Welfare data show 23.88 million people insured with a 99.9% coverage rate and 90% satisfaction in 2023. By contrast, the OECD still reports only 93% coverage of a core set of services in the United States in 2025. citeturn12view0turn12view1turn12view2turn16view1turn16view4turn16view7turn13view0turn35search3turn13view4

The systems under the greatest strain are not all the same. The United Kingdom and Canada are primarily under access and queueing strain. Germany and France are more visibly under fiscal and workforce strain. Taiwan is a high-performing national insurance system with clear financing and remote-access pressure points. Brazil and especially South Africa remain under equity and capacity strain linked to lower national income, public-private fragmentation, and uneven access. The United States is under affordability and administrative strain to a degree unmatched by peers, despite excellent pockets of specialist and acute care. OECD’s 2026 spending outlook also warns that revenues in social insurance systems have not fully caught up with spending growth, forcing reserve drawdowns or additional state support in some countries. citeturn12view2turn11view5turn13view0turn13view1turn5search7turn37search3turn17search0turn20search4turn20search7turn13view3turn42search1turn44search6

The policy implication is not that one model should simply be copied wholesale. Rather, the evidence points to a set of design lessons. Systems do best when coverage is automatic, cost sharing is modest, prices are regulated, administrative pathways are standardized, and primary care plus remote-area access are intentionally strengthened. Taiwan’s NHI programs for remote areas and telemedicine are a good example of a targeted reform with measurable uptake and high reported satisfaction; Mirror, Mirror 2024 similarly finds that lower-complexity payment systems in countries like the United Kingdom and Australia are associated with much stronger administrative efficiency than in the United States or Switzerland. citeturn37search3turn44search2turn44search6

Comparative model overview

The country evidence supports a practical, model-based pattern. Beveridge / NHS-style systems such as the United Kingdom and Sweden excel at universality and administrative simplicity, but they become vulnerable to waiting-time pressure when workforce growth, hospital capacity, and social care do not keep pace with demand. OECD shows the United Kingdom’s relatively low bed supply at 2.4 per 1,000 and doctor supply at 3.4 per 1,000, while Sweden pairs equally universal coverage with stronger outcomes and higher staffing, especially in long-term care. citeturn8view1turn16view7turn16view8

Social health insurance systems such as Germany, France, Japan, and the Netherlands usually achieve very strong coverage, low unmet need, and good to excellent outcomes, but their liabilities are fiscal: aging, labor-cost growth, and contribution-based financing can create structural deficits if expenditure rises faster than payroll-linked revenues. Germany, France, Japan, and the Netherlands all combine universal coverage with high prepayment shares, but their outcomes per dollar vary considerably, with Japan and France performing better than Germany on that basis. OECD’s 2026 outlook explicitly highlights this financing problem in some social insurance systems. citeturn12view0turn12view1turn16view1turn16view4turn11view3turn11view4turn16view5turn16view2turn5search7

National health insurance systems such as Canada and Taiwan offer a different balance. They are very strong on universal entitlement and financial protection against catastrophic medical bills for core services, but they can drift into rationing by waiting if payment levels, provider supply, or infrastructure are too tight. Canada’s 2025 OECD profile shows universal core coverage, but only 50% satisfaction with healthcare availability and 9.1% reported unmet need. Taiwan, by contrast, reports 99.9% NHI coverage, 90% satisfaction, and lower aggregate spending as a share of GDP, illustrating how organizational details matter as much as the model label itself. citeturn12view2turn35search3turn36view0turn27search12

Mixed public-private systems can work well if they are tightly regulated, but the U.S. case shows the downside when prices, coverage rules, and billing remain fragmented. OECD reports U.S. spending of $14,885 per person and 17.2% of GDP, life expectancy of only 78.4 years, preventable mortality of 217 per 100,000, and treatable mortality of 95 per 100,000. OECD also reports U.S. healthcare prices 52% above the OECD average, while the 2020 Annals study estimates U.S. administrative spending at 34.2% of national health expenditures versus 17.0% in Canada. Commonwealth Fund benchmarking in 2024 again ranked the U.S. last overall among peer systems and among the worst on equity and administrative efficiency. citeturn13view3turn13view5turn43view0turn42search1turn44search2turn44search6

Selected middle-income systems show that model design alone cannot overcome lower fiscal capacity and deeper structural inequality. Brazil’s SUS remains a notable universal-coverage project, but World Bank data still show 26.23% out-of-pocket spending, 9.7% of GDP devoted to health, and $2,070 PPP per person in 2023, alongside 2024 life expectancy of 76 and infant mortality of 12. South Africa spends 8.91% of GDP, but with only about $1,354 PPP per person, life expectancy of 66, infant mortality around 24, and maternal mortality of 118, making it the most stressed system in this comparison. citeturn17search0turn19search2turn26search1turn26search2turn19search4turn21search4turn20search6turn21search5turn22search2turn20search4turn25search2turn20search7

Comparative table of country metrics

The table below prioritizes metrics that were directly retrievable from recent official or primary sources. Most OECD values are from Health at a Glance 2025 country notes and therefore mainly reflect 2023 or 2024 data; for several OECD rows, the latest directly retrieved out-of-pocket shares came from Health at a Glance 2023 country notes. Brazil and South Africa values come mainly from World Bank / WHO expenditure and mortality indicators. Taiwan values come from MOHW / NHIA official reports. Some requested metrics, especially directly comparable recent wait times, cancer survival, PROMs, and full infant/maternal series across all countries, were not consistently extractable from the official sources retrieved here and are addressed later as limitations. citeturn12view0turn12view1turn12view2turn13view3turn35search3turn27search12turn26search1turn22search2

Country Model Coverage and financial protection Access and equity signal Outcomes signal Cost signal Reading
United Kingdom NHS / Beveridge Universal core coverage; 82% of spending covered by mandatory prepayment; OOP share 13% in latest extracted OECD country note Satisfaction 61%; 3.4 doctors and 2.4 beds per 1,000 Life expectancy 81.0; treatable mortality 71; preventable mortality 156 $6,747 PPP per person; 11.1% of GDP Good value, but access strain is now a central weakness. Source: citeturn13view0turn13view1turn13view2turn8view0
Germany Social insurance / Bismarck Universal core coverage; 86% mandatory prepayment; OOP 12%; unmet need 0.8% Satisfaction 81%; strong financial protection; Germany’s 2023 country profile also reports minimal income gradient in unmet need Life expectancy 81.1; treatable mortality 66; preventable mortality 129 $9,365 PPP; 12.3% of GDP Excellent access and equity, but comparatively expensive for the outcomes achieved. Source: citeturn12view0turn11view0turn11view3turn42search2
France Social insurance / Bismarck Universal core coverage; 84% mandatory prepayment; OOP 9%; unmet need 4.1% Satisfaction 60%; weaker reported access than Germany despite strong financial protection Life expectancy 83.0; treatable mortality 48; preventable mortality 114 $7,367 PPP; 11.5% of GDP One of the strongest all-round performers on outcomes, equity, and cost control. Source: citeturn12view1turn11view1turn11view4
Canada National health insurance Universal core coverage; 70% mandatory prepayment; OOP 14%; unmet need 9.1% Satisfaction 50%; 2.7 doctors and 2.5 beds per 1,000 Life expectancy 81.7; treatable mortality 58; preventable mortality 126 $7,301 PPP; 11.3% of GDP Sound outcomes and universality, but timeliness is a major drag on patient experience. Source: citeturn12view2turn11view2turn11view5
Taiwan National health insurance 23.88 million insured; 99.9% coverage; 90% satisfaction in 2023 30,838 contracted facilities; 91.6% of medical institutions contracted to NHI; remote-area programs report ~95% satisfaction Life expectancy 80.2 in 2023; infant mortality 4.3 in 2023 NHE 7.3% of GDP in 2024; per-capita NHE NTD 80,719; public share of CHE 65.5% in 2022 Exceptional access and value; a leading national-insurance benchmark. Source: citeturn35search3turn35search4turn35search1turn27search12turn36view0turn37search3
United States Mixed public-private 93% core coverage; OOP 11% in latest extracted OECD note, but major underinsurance and complexity remain Satisfaction 75%, but avoidable admissions 733; Commonwealth Fund ranks the U.S. among the worst on equity and admin burden Life expectancy 78.4; treatable mortality 95; preventable mortality 217; strong AMI/stroke mortality $14,885 PPP; 17.2% of GDP; health prices 52% above OECD average High-end acute care is strong, but the worst aggregate value in the group. Source: citeturn13view3turn13view5turn7search5turn43view0turn44search2turn44search6
Japan Universal insurance Universal core coverage; 85% mandatory prepayment; satisfaction 80% Good access; no comparable unmet-need figure in the retrieved note Life expectancy 84.1; treatable mortality 49; preventable mortality 86 $5,790 PPP; 10.6% of GDP Best outcome-per-dollar benchmark in this synthesis, though aging pressures are severe. Source: citeturn16view3turn16view4turn16view5
Netherlands Regulated competition / social insurance Universal core coverage; 83% mandatory prepayment; unmet need 0.6% Satisfaction 83%; avoidable admissions 364 Life expectancy 81.9; treatable mortality 49; preventable mortality 100 $8,436 PPP; 10.0% of GDP Very strong on equity and coordination, with high but not excessive cost. Source: citeturn16view0turn16view1turn16view2
Sweden Tax-funded / Beveridge Universal core coverage; 86% mandatory prepayment; unmet need 2.3% Satisfaction 75%; very strong access/quality score in OECD note Life expectancy 83.4; treatable mortality 47; preventable mortality 86 $7,871 PPP; 11.3% of GDP Among the best combinations of outcomes and equity in a tax-funded model. Source: citeturn16view6turn16view7turn16view8
Brazil Universal public system with mixed financing SUS is universal by law; OOP 26.23% Universal entitlement, but weaker financial protection and known public-private fragmentation Life expectancy 76 in 2024; infant mortality 12 in 2024; maternal mortality 67 in 2023 $2,070 PPP; 9.7% of GDP Strong universal aspiration and moderate cost, but uneven equity and weaker outcomes than high-income peers. Source: citeturn17search0turn19search2turn26search1turn26search2turn19search4turn21search4turn26search3
South Africa Segmented public-private middle-income system OOP 6.69%; very low OOP does not imply equity because access is highly segmented Outcomes indicate deep inequality and capacity gaps Life expectancy 66 in 2024; infant mortality about 24 in 2024; maternal mortality 118 in 2023 $1,353.75 PPP; 8.91% of GDP Most stressed system in the sample: weak outcomes despite substantial GDP share devoted to health. Source: citeturn20search6turn21search5turn22search2turn20search4turn25search8turn20search7

A compact “equity heatmap” makes the pattern clearer. The symbols below summarize the direction of travel rather than adding new data: 🟩 strong, 🟨 mixed, 🟥 weak. The judgments are based on coverage breadth, direct financial burden, unmet need, satisfaction, and equity findings from OECD, Commonwealth Fund, and Taiwan MOHW sources. citeturn12view0turn12view1turn12view2turn13view3turn16view1turn16view4turn16view7turn35search3turn44search2turn44search6

Country Coverage breadth Financial protection Timely access Socioeconomic equity
Japan 🟩 🟩 🟩 🟨
Taiwan 🟩 🟩 🟩 🟩
France 🟩 🟩 🟨 🟩
Sweden 🟩 🟩 🟩 🟩
Netherlands 🟩 🟩 🟩 🟩
Germany 🟩 🟩 🟩 🟩
United Kingdom 🟩 🟩 🟨 🟩
Canada 🟩 🟨 🟥 🟨
Brazil 🟩 🟨 🟨 🟥
South Africa 🟨 🟨 🟥 🟥
United States 🟥 🟥 🟨 🟥

Adjusted ranking and value analysis

The ranking below is an author-adjusted synthesis, not a mechanical league table. It weights recent official outcomes against spending, then adjusts for equity and access strain. The most important components are life expectancy, treatable or preventable mortality where available, infant/maternal mortality where OECD-style mortality metrics were not retrieved, spending per capita and as a share of GDP, breadth of coverage, unmet need, and direct patient financial exposure. Because social determinants, age structures, and data availability differ across countries, the ranking should be read as an analytic ordering with uncertainty bands, especially in the middle of the table. citeturn11view0turn11view1turn11view2turn13view3turn16view3turn16view6turn35search4turn19search4turn20search4

Approximate composite rank Country Why it lands here
1 Japan The strongest outcomes-per-dollar combination among the high-income systems retrieved here: life expectancy 84.1, low treatable mortality, universal access, and spending below the OECD average. citeturn16view3turn16view4turn16view5
2 France Very strong mortality outcomes and life expectancy with lower spending than Germany, Canada, Sweden, or the Netherlands, plus strong financial protection. citeturn11view1turn12view1turn11view4
3 Taiwan Not fully PPP-comparable in the retrieved data, but 99.9% coverage, 90% satisfaction, low GDP share, and strong infant mortality make it one of the clearest high-value systems. citeturn35search3turn35search1turn27search12turn36view0
4 Sweden Excellent outcomes and equity, though at a somewhat higher cost than France or Japan. citeturn16view6turn16view7turn16view8
5 Netherlands Exceptional equity and coordination with very low unmet need, but not quite the best outcomes-per-dollar among European leaders. citeturn16view0turn16view1turn16view2
6 Germany One of the best systems for financial security and low unmet need, but expensive and less efficient on aggregate outcomes than France, Sweden, or Japan. citeturn12view0turn11view0turn11view3turn42search2
7 United Kingdom Still a relatively good population-health bargain, but current access strain prevents it from ranking higher for patients. citeturn13view0turn13view1turn13view2turn8view0
8 Canada Good outcomes and universal coverage, but queueing and high unmet need substantially weaken patient value. citeturn12view2turn11view2turn11view5
9 Brazil Better value than its income level alone would predict, but still far behind high-income universal systems on outcomes and financial protection. citeturn19search2turn26search1turn26search2turn19search4turn21search4turn26search3
10 South Africa Large national effort and substantial GDP share devoted to health, but severe segmentation and much poorer outcomes dominate. citeturn20search6turn21search5turn22search2turn20search4turn25search8turn20search7
11 United States The weakest balance of outcomes, equity, and cost by a very large margin. citeturn13view3turn13view5turn43view0turn42search1turn44search2turn44search6

A simple “spending versus outcomes” matrix captures the logic of the ranking.

Lower-to-moderate spending Higher spending
Better outcomes Japan, Taiwan, France Sweden, Netherlands
Weaker outcomes Brazil Germany, United Kingdom, Canada, United States, South Africa

This is also where the models diverge most clearly. NHS and tax-funded systems usually score well on administrative simplicity and patient financial protection. Social insurance systems do particularly well on breadth of access and often on timeliness. National insurance systems can be extremely efficient if payment systems are disciplined and digital infrastructure is strong, as Taiwan illustrates. The mixed U.S. system is the least coherent bundle across the three core dimensions: access, outcomes, and costs. citeturn44search2turn44search6turn35search3turn13view3

Systems under strain

The pattern of strain is causal rather than accidental. When systems combine rising chronic disease and aging with labor shortages, underpriced public payment, fragmented purchasing, or weak primary care capacity, access problems and fiscal stress follow. OECD’s 2026 outlook explicitly notes that in several social insurance systems, revenues have not caught up with spending growth, forcing reserve drawdowns or extra government support. OECD’s country notes simultaneously show that some of the systems with the strongest equity guarantees are also operating with relatively tight physical or workforce capacity. citeturn5search7turn11view3turn11view4turn11view5turn13view1

United Kingdom. The UK still delivers universal coverage and comparatively low treatable mortality for the money, but the country note shows only 61% satisfaction with availability, doctor density below the OECD average, and bed supply far below the OECD average. In practice, that is the classic NHS strain pattern: good financial protection, worsening timeliness. citeturn13view0turn13view1turn13view2

Canada. Canada’s problem is not lack of universal entitlement; it is the gap between entitlement and timely delivery. OECD reports 9.1% unmet need, only 50% satisfaction with healthcare availability, low doctor supply, and low bed supply. That is why Canada scores much better on equity than on access. citeturn12view2turn11view5

Germany and France. These systems remain high performers, but they are under financing and workforce stress rather than access collapse. Germany combines universal coverage and just 0.8% unmet need with very high spending and strong hospital capacity, but its outcomes do not fully justify its cost; France achieves outstanding outcomes at lower cost, yet its unmet need is higher than Germany’s and long-term-care staffing is thin. OECD’s 2026 fiscal outlook makes clear why these systems are being pushed toward hospital, payment, and contribution reforms. citeturn12view0turn11view3turn12view1turn11view4turn5search7

Taiwan. Taiwan remains a success story, but the pressure points are visible. Official MOHW statistics show 99.9% coverage and strong satisfaction, yet they also show active remote-area subsidy programs, telemedicine expansion, and major-illness spending that already accounts for a large share of annual medical expenditure. Those are hallmarks of a system trying to preserve broad access while holding down the overall spending envelope. citeturn35search3turn37search3

Brazil. Brazil’s system is under strain because universal legal entitlement sits on top of weaker financial protection and lower per-capita resources than high-income peers. World Bank data show markedly lower spending per person than OECD systems and a much higher OOP share than France, Germany, Canada, the UK, or the U.S. OECD-style treatable mortality is not available in the extracted sources, but life expectancy, infant mortality, and maternal mortality still leave Brazil far behind the high-income leaders. citeturn19search2turn26search2turn19search4turn21search4turn26search3

South Africa. South Africa appears to be the most stressed system in the sample because its outcomes are weak even relative to its GDP share of health spending. Official World Bank indicators show only 66 years of life expectancy, infant mortality of roughly 24, maternal mortality of 118, and spending of almost 9% of GDP. The low OOP share should not be read as strong equity here; it is consistent with a segmented public-private system in which many people lack timely access to high-quality care without a large out-of-pocket transaction at the point of use. citeturn20search6turn21search5turn20search4turn25search8turn20search7

United States. The U.S. strain is different from all of the above. It is not mainly about too little money; it is about price, fragmentation, and administrative complexity. OECD reports both the highest spending and the highest or near-highest price levels. The Annals comparison finds administration consuming 34.2% of national health expenditures in the U.S. versus 17.0% in Canada, and Commonwealth Fund work still places the U.S. at the bottom overall because lower-income adults are much more likely to skip needed care and both patients and clinicians face much heavier billing and paperwork burdens. citeturn13view3turn43view0turn42search1turn44search2turn44search6

flowchart TD
    A[Aging and chronic disease burden] --> E[Higher demand for care]
    B[Workforce shortages and maldistribution] --> E
    C[Weak primary care and poor care coordination] --> F[More avoidable admissions and hospital dependence]
    D[High prices and administrative complexity] --> G[Budget pressure and affordability problems]
    E --> H[Longer waits and unmet need]
    F --> H
    G --> I[Political pressure for rationing, higher contributions, or benefit redesign]
    H --> J[Lower patient satisfaction and widening inequality]
    I --> J
    J --> K[System strain visible to patients]

Policy lessons and reform evidence

The most durable lesson is that automatic or near-automatic coverage matters. Every country in the stronger-performing cluster has achieved universal or nearly universal coverage for core services, whether through taxation, social insurance, or national insurance. Germany, France, Sweden, Japan, the Netherlands, the United Kingdom, and Canada all report full-population core coverage in OECD notes, and Taiwan reports 99.9% coverage. The U.S. remains the only rich-country case in this comparison without universal core coverage, and that difference remains highly consequential for equity. citeturn12view0turn12view1turn12view2turn13view0turn16view1turn16view4turn16view7turn35search3turn13view4

The second lesson is that financial protection is not just about insurance cards; it is about what the system finances before patients reach the point of care. France, Germany, Japan, Sweden, the UK, and the Netherlands all finance 82% to 86% of health spending through mandatory prepayment in the retrieved OECD notes, and the systems with the smallest unmet-need rates in this set are Germany and the Netherlands. By contrast, Brazil’s OOP share remains 26.23%, and the U.S., despite an OOP share that looks modest in national-account terms, still leaves many households underinsured because national-account OOP shares do not capture the depth of deductibles, coinsurance, billing disputes, or uncovered benefits. citeturn12view0turn12view1turn13view0turn16view1turn16view4turn16view7turn19search2turn44search6

The third lesson is that price regulation and purchasing discipline matter more than the financing label alone. OECD’s price-level analysis shows that the same healthcare basket costs 52% more than the OECD average in the United States and Switzerland, while countries such as France have much lower healthcare price levels. This is one reason the U.S. cannot “grow its way” out of cost problems: high spending is not simply buying proportionately more care. Taiwan’s low system-wide GDP share and Japan’s below-average per-capita spend show that broad coverage need not imply U.S.-style expenditure levels if prices and budgets are governed tightly. citeturn43view0turn16view5turn27search12

The fourth lesson is that administrative simplification is a real policy lever. Commonwealth Fund’s 2024 international comparison identifies the UK and Australia as top performers on administrative efficiency and places the U.S. and Switzerland at the bottom; the same report explicitly links U.S. complexity to the mix of public and private insurers and thousands of plan designs. The 2020 Annals paper adds the clearest hard estimate in this synthesis: U.S. insurers and providers spent $2,497 per capita on administration, compared with $551 in Canada. For countries under cost pressure, reducing billing complexity is not a cosmetic reform; it is one of the largest credible sources of efficiency gain. citeturn44search2turn44search6turn42search1

The fifth lesson is that targeted access reforms can work even inside a cost-controlled universal system. Taiwan’s official 2024 Health and Welfare Report documents several examples: 95% satisfaction in its remote-area access plan; telemedicine use for 7,992 specialty consultations in 2023; copayment discounts in recognized medically underserved areas; and catastrophic-illness certification that exempts patients from copayments. This is an especially important lesson for Canada, the UK, Brazil, and South Africa: broad entitlement must be paired with concrete rural, remote, and workforce deployment policy if equity is to become real access. citeturn37search3

A final lesson is more cautionary: more spending does not guarantee better patient-reported outcomes. OECD’s PaRIS program and the related 2025 report on whether healthcare delivers note substantial variation in patient-reported outcomes and experiences among people living with chronic conditions; the implication is that organization of care, continuity, and patient-centered design matter at least as much as the aggregate spending level. That point is consistent with the broader pattern in this report: France, Japan, Sweden, and Taiwan translate spending into patient benefit more effectively than the United States, Germany, or Canada do at the margin. citeturn5search12turn11view4turn16view5turn16view8turn35search3turn13view3turn11view3turn11view5

Open questions and limitations

This report is strongest on coverage, financial protection, life expectancy, treatable/preventable mortality, and spending because those were the indicators most consistently available from the official sources retrieved. It is weaker on fully comparable recent wait-time series, country-by-country infant and maternal mortality across all OECD systems, disease-specific cancer survival, and standardized patient-reported outcomes. Those data exist in parts, but in the sources retrieved here they were not evenly extractable across the full country set. OECD itself emphasizes that countries vary in data availability across access and quality indicators, and the WHO UHC pages retrieved here describe the framework clearly but did not provide easily extractable country values in the fetched pages. citeturn10view0turn10view1turn10view2turn38search0turn38search4

There is also an unavoidable comparability problem across income levels. Brazil and South Africa should not be judged by the same standard as Sweden or Japan without accounting for income, disease burden, violence, HIV/TB burden, and broader social determinants. That said, the direction of the findings is still informative: Brazil’s universal public design buys more access than its resource level alone might suggest, while South Africa’s segmentation and weak outcome profile indicate a system under more acute stress than its health-spending share of GDP would imply. citeturn26search1turn26search2turn20search4turn21search5turn22search2

The bottom-line judgment, after adjusting for these limits, is robust. The best results for patients come from systems that are universal, price-disciplined, administratively simpler, and primary-care oriented. The systems most clearly under strain are those where either capacity lags entitlement, as in the UK and Canada, or where prices, administrative complexity, and fragmented risk pooling overwhelm the system, as in the U.S., or where structural inequality and uneven public-private access dominate, as in South Africa and parts of Brazil. citeturn13view0turn12view2turn13view3turn43view0turn42search1turn20search4turn26search2